Automatic Quantitative Analysis software for Alzheimer’s Disease

Heuron-Alzheimer provides information by PET & 3D T1 MRI-based imaging for Alzheimer's Disease. This solution automatically quantifies multi-tracer bindings localized to 97 brain segmentation and 4 reference regions identified by 3D T1 MRI segmentation.  
  • FDA, CE, MFDS approved
  • Commercially available

Quantitative analysis of Beta-amyloid protein by SUVR
(Standardized Uptake Value Ratio)

It can be used in an objective solution on the clinical study fields, enabling quantitative analysis of amyloid PET imaging
and thus delivering data on the brain location through the integration with MRI images.

SUVR is the most common quantitative method used to make regional comparisons within a subject as well as between subjects and computed as the degree of radiotracer uptake in a target region of interest with respect to a reference region.

'Heuron-Alzheimer' supports automatic quantification of the Beta-amyloid protein in Alzheimer's Disease.
Calculating SUVR automatically for analyzing deposit level of Beta-amyloid

Comparison of average required
time for SUVR calculation

(*Time may vary subject to read-in area)

Veuron-Brain-pAb

patient info
ID 30641163 Sex Male
Name ANONYMITY Age 68Y
Results
Global 0.76
Frontal Lobe 0.81
Parietal Lobe 0.78
Temporal Lobe 0.66
Occipital Lobe 0.55
Post. Cingulate 0.77

(*Result may vary depending upon type of isotope)

Amyloid beta, biomarker for Alzheimer's Disease

Alzheimer's Disease(AD) pathogenesis  is widely believed to be driven by the production
and deposition of the amyloid beta plaque.

Amyloid beta is the first protein that begins to accumulate when Alzheimer's
Disease(AD) is contracted, and it is used as an important biomarker in diagnosing Alzheimer's Disease(AD) .

'Heuron-Alzheimer' analyzes amyloid PET images and presents quantitative results to support diagnosis and clinical trials.